This time next year, I hope I can write a column with the headline “2019: The year of cooperation and communication in the clinical trial industry.” We’ve made some exciting progress toward that end in 2018. Now it’s time to take it to the next level. Read More Source: Outsourcing Pharma
The sometimes-fragile relationship between sponsors and contract research organizations (CROs) probably won’t be helped by alarming new data suggesting clinical trial costs have nearly doubled since 2010, according to Deloitte’s 8th annual report, “A New Future for R&D?” Worse still, trial costs have grown in six of the past eight years. In the report, Deloitte […]
While millennials may have a hard time believing it, there was a time when people didn’t understand they could order a lamp, or groceries, or that obscure Rolling Stones CD from the same site with same-day delivery. Tech giant Amazon is ubiquitous at meeting such demands today, but it wasn’t always so. Therein lies a […]
While mission-critical activities related to imminent safety concerns will remain largely untouched during the latest partial government shutdown, activities involving the payment of fees are now in a state of suspended animation. The Food and Drug Administration (FDA) will continue to support activities funded by carryover user fee balances, which allows it to continue to […]
New Year’s resolutions are in the air. Maybe it’s time to renew that gym membership? Should you be calling your mother more often? And when are you going to pick up that electric guitar you bought in 2016? However, embracing change is rarely easy—that’s especially true in the clinical trial industry. There are many reasons […]
